Nomura Holdings’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-23,578
Closed -$34K 919
2025
Q1
$34K Sell
23,578
-42
-0.2% -$60 ﹤0.01% 994
2024
Q4
$52K Buy
23,620
+42
+0.2% +$92 ﹤0.01% 1444
2024
Q3
$38.9K Hold
23,578
﹤0.01% 853
2024
Q2
$52.3K Hold
23,578
﹤0.01% 1065
2024
Q1
$63.2K Sell
23,578
-13,767
-37% -$36.9K ﹤0.01% 910
2023
Q4
$112K Sell
37,345
-78,676
-68% -$235K ﹤0.01% 1042
2023
Q3
$114K Hold
116,021
﹤0.01% 710
2023
Q2
$161K Hold
116,021
﹤0.01% 640
2023
Q1
$184K Sell
116,021
-73,278
-39% -$117K ﹤0.01% 721
2022
Q4
$1.17M Buy
+189,299
New +$1.17M ﹤0.01% 477
2021
Q4
Sell
-31,045
Closed -$369K 1766
2021
Q3
$369K Sell
31,045
-57,563
-65% -$684K ﹤0.01% 1135
2021
Q2
$1.88M Buy
88,608
+17,081
+24% +$363K ﹤0.01% 586
2021
Q1
$2M Sell
71,527
-217,291
-75% -$6.09M ﹤0.01% 580
2020
Q4
$7.53M Buy
288,818
+63,818
+28% +$1.66M 0.01% 292
2020
Q3
$8.36M Hold
225,000
0.02% 228
2020
Q2
$11.6M Hold
225,000
0.04% 135
2020
Q1
$7.08M Sell
225,000
-325,000
-59% -$10.2M 0.03% 151
2019
Q4
$32.7M Hold
550,000
0.12% 65
2019
Q3
$19.8M Hold
550,000
0.07% 120
2019
Q2
$25.1M Hold
550,000
0.11% 85
2019
Q1
$22M Buy
550,000
+85,300
+18% +$3.42M 0.09% 97
2018
Q4
$21.3M Buy
464,700
+184,700
+66% +$8.48M 0.08% 87
2018
Q3
$12.7M Buy
280,000
+30,000
+12% +$1.36M 0.04% 169
2018
Q2
$9.8M Buy
250,000
+245,000
+4,900% +$9.6M 0.03% 215
2018
Q1
$362 Buy
+5,000
New +$362 ﹤0.01% 878